![investigadors_bonaventura_clotet.jpg](/sites/default/files/styles/1_1_small/public/imports/dest/drupal7_imatges/investigadors_bonaventura_clotet.jpg?h=1bb3e1f8&itok=ZCzos79j)
Bonaventura Clotet Sala
Research against HIV/AIDS has marked the professional career of an internationally renowned researcher. Consult his biography.
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.
Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients.
Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.
VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.